Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 31, 2016
Cash flows provided by (disbursed for) operating activities:
Net income	$ 157,160	$ 150,120	$ 163,776
Adjustments to reconcile net income to net cash provided by operating activities:
Restructuring and related impairment charges	5,593	69,601
Gain on divestiture		(28,875)
Depreciation and amortization	144,124	146,719	140,869
Impairment of assets	5,999		24,877
Stock-based compensation	8,148	16,093	18,761
Loss reclassified from accumulated other comprehensive income to net income	1,301	2,080	5,307
Deferred income taxes	21,657	(61,306)	(14,457)
Provision for inventory obsolescence	740	1,684	1,324
Allowances for accounts receivable	6,963	4,215	3,365
Pension and postretirement plans (benefit) expense	8,474	(897)	2,238
Other	(4,839)	(6,203)	(106)
Qualified pension plan contributions	(40,700)	(1,605)	(1,000)
Changes in operating assets and liabilities, net of acquisitions and disposals:
Accounts receivable, net	(8,278)	(11,762)	(7,888)
Inventories, net	(8,424)	(7,801)	(1,526)
Hedging activities, net	2,725	(15,727)	13,592
Other assets	5,120	(12,557)	(3,441)
Accounts payable	60,863	10,840	(519)
Other accrued liabilities	(70,733)	42,770	11,390
Net cash provided by operating activities	295,893	297,389	356,562
Cash flows provided by (disbursed for) investing activities:
Purchases of property, plant and equipment	(99,422)	(75,232)	(101,727)
Repurchase of independent distributor territories	(3,128)	(6,460)	(8,871)
Cash paid at issuance of notes receivable	(28,454)	(25,566)	(8,577)
Principal payments from notes receivable	26,883	24,875	22,272
Acquisition of businesses, net of cash acquired	(200,174)
Proceeds from sale of mix plant		41,230
Proceeds from sales of property, plant and equipment	1,913	3,935	17,667
Other investing activities	577	1,823	2,522
Net cash disbursed for investing activities	(301,805)	(35,395)	(76,714)
Cash flows provided by (disbursed for) financing activities:
Dividends paid, including dividends on share-based payment awards	(150,214)	(140,982)	(131,073)
Exercise of stock options	791	19,313	27,631
Payments for debt issuance costs	(100)	(729)	(4,380)
Stock repurchases	(2,489)	(2,671)	(126,300)
Change in bank overdrafts	4,851	(14,206)	1,914
Proceeds from debt borrowings	200,900	611,900	2,090,492
Debt and capital lease obligation payments	(27,650)	(735,900)	(2,146,100)
Net cash provided by (disbursed for) financing activities	26,089	(263,275)	(287,816)
Net increase (decrease) in cash and cash equivalents	20,177	(1,281)	(7,968)
Cash and cash equivalents at beginning of period	5,129	6,410	14,378
Cash and cash equivalents at end of period	25,306	5,129	6,410
Schedule of non cash investing and financing activities:
Capital and right-to-use lease obligations	1,977	3,337	15,622
Distributor routes sold with deferred gains, net	8,770	9,707	5,213
Increase in property, plant and equipment from financing			4,855
Purchase of property, plant and equipment included in accounts payable	901	2,991	5,203
Cash paid during the period for:
Interest	32,747	34,196	26,897
Income taxes paid, net of refunds of $40, $236 and $12,212, respectively	13,697	71,996	84,108
Executive Deferred Compensation Plan
Schedule of non cash investing and financing activities:
Issuance of executive deferred compensation plan common stock	124	38	114
Distributor Notes Receivable
Schedule of non cash investing and financing activities:
Issuance of notes receivable on new distribution territories, net	$ 45,528	$ 60,594	$ 23,352